Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Monneaux, F.
Right arrow Articles by Muller, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monneaux, F.
Right arrow Articles by Muller, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 9, 1155-1163, September 2001
© 2001 Japanese Society for Immunology

Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZB x NZW)F1 lupus mice

Fanny Monneaux, Hélène Dumortier2, Guenter Steiner1, Jean-Paul Briand and Sylviane Muller

Institut de Biologie Moléculaire et Cellulaire, UPR 9021 Centre National de la Recherche Scientifique, 15 rue René Descartes, 6700 Strasbourg, France
1 Division of Rheumatology, Department of Internal Medicine III, and Institute of Medical Biochemistry, University of Vienna, Dr Bohr-Gasse 9, A-1030 Vienna, Austria
2 Present address: Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, The Netherlands.

Correspondence to: S. Muller

(NZB x NZW)F1 and MRL/Faslpr lupus mice present a similar phenotype with a spectrum of autoantibodies associated with very severe nephritis. It is thought, however, that in contrast to other lupus-prone mice such as MRL/Faslpr mice, (NZB x NZW)F1 mice do not generate autoantibodies to ribonucleoproteins (RNP) Sm/RNP. In this study, we demonstrate that contrary to previous reports, the autoimmune response directed against Sm/RNP antigens also occurs in NZB x NZW mice. CD4+ T cells from unprimed 10-week-old NZB x NZW mice proliferate and secrete IL-2 in response to peptide 131–151 of the U1-70K protein, which is known to contain a Th epitope recognized by CD4+ T cells from MRL/Faslpr mice. Peptide 131–151, which was found to bind I-Ak and I-Ek class II MHC molecules, also bound both I-Ad and I-Ed molecules. This result led us to also re-evaluate longitudinally the anti-Sm/RNP antibody response in NZB x NZW mice. We found that 25-week-old mice do produce antibodies reacting with several small nuclear and heterogeneous nuclear (hn) RNP proteins, such as SmD1, U1-70K and hnRNP A2/B1 proteins. The fine specificity of these antibodies was studied with overlapping synthetic peptides. The same antigenically positive and negative peptides were characterized in MRL/Faslpr and NZB x NZW mice in the three proteins. This new finding can help to understand the mechanisms involved in the development of the anti-Sm/RNP antibody response and, particularly, the role played by non-MHC genes in this autoimmune response.

Keywords: autoimmunity, epitopes, lupus animal models, T lymphocytes

Transmitting editor: S. Izui


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
D. T. Teachey, A. E. Seif, V. I. Brown, M. Bruno, R. M. Bunte, Y. J. Chang, J. K. Choi, J. D. Fish, J. Hall, G. S. Reid, et al.
Targeting Notch signaling in autoimmune and lymphoproliferative disease
Blood, January 15, 2008; 111(2): 705 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Woods, F. Monneaux, P. Soulas-Sprauel, S. Muller, T. Martin, A.-S. Korganow, and J.-L. Pasquali
Influenza Virus-Induced Type I Interferon Leads to Polyclonal B-Cell Activation but Does Not Break Down B-Cell Tolerance
J. Virol., November 15, 2007; 81(22): 12525 - 12534.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Monneaux, J. Hoebeke, C. Sordet, C. Nonn, J.-P. Briand, B. Maillere, J. Sibillia, and S. Muller
Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog
J. Immunol., November 1, 2005; 175(9): 5839 - 5847.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Fournel, S. Neichel, H. Dali, S. Farci, B. Maillere, J.-P. Briand, and S. Muller
CD4+ T Cells from (New Zealand Black x New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H3
J. Immunol., July 15, 2003; 171(2): 636 - 644.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. S. Deshmukh, C. C. Kannapell, and S. M. Fu
Immune Responses to Small Nuclear Ribonucleoproteins: Antigen-Dependent Distinct B Cell Epitope Spreading Patterns in Mice Immunized with Recombinant Polypeptides of Small Nuclear Ribonucleoproteins
J. Immunol., May 15, 2002; 168(10): 5326 - 5332.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.